Plerixafor and resatorvid inhibit hepatitis B virus in vitro by upregulating elongation factor Tu GTP-binding domain containing 2.

Jinyuan Cai,Yuwen Li,Pingping Hu,Ruirui Xu,Hui Yuan,Wen Zhang,Tiantong Feng, Rui Liu,Wenting Li,Chuanlong Zhu

Frontiers in cellular and infection microbiology（2023）

引用 0|浏览29

暂无评分

摘要

We established a convenient model for screening compounds that target EFTUD2 and further identified plerixafor and resatorvid as novel HBV inhibitors . Our findings provided information on the development of a new class of anti-HBV agents that act on host factors rather than viral enzymes.

查看译文

关键词

EFTUD2,hepatitis B virus,plerixafor,resatorvid,small-molecule agents

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要